These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 17878466

  • 1. Inhaled corticosteroids in chronic obstructive pulmonary disease.
    Suissa S, McGhan R, Niewoehner D, Make B.
    Proc Am Thorac Soc; 2007 Oct 01; 4(7):535-42. PubMed ID: 17878466
    [Abstract] [Full Text] [Related]

  • 2. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug 01; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 3. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug 01; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 4. Inhaled corticosteroids in chronic obstructive pulmonary disease: a review.
    Telenga ED, Kerstjens HA, Postma DS, Ten Hacken NH, van den Berge M.
    Expert Opin Pharmacother; 2010 Feb 01; 11(3):405-21. PubMed ID: 20102305
    [Abstract] [Full Text] [Related]

  • 5. The place of inhaled corticosteroids in chronic obstructive pulmonary disease.
    Selroos O.
    Curr Med Res Opin; 2004 Oct 01; 20(10):1579-93. PubMed ID: 15462691
    [Abstract] [Full Text] [Related]

  • 6. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP.
    Am J Med; 2006 Oct 01; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [Abstract] [Full Text] [Related]

  • 7. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
    Ann Pharmacother; 2010 Apr 01; 44(4):613-22. PubMed ID: 20233915
    [Abstract] [Full Text] [Related]

  • 8. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A, Gessner C, Hoheisel G, Juergens U.
    Pneumologie; 2008 Jul 01; 62(7):430-7. PubMed ID: 18398787
    [Abstract] [Full Text] [Related]

  • 9. Methodological issues in therapeutic trials of COPD.
    Suissa S, Ernst P, Vandemheen KL, Aaron SD.
    Eur Respir J; 2008 May 01; 31(5):927-33. PubMed ID: 18216056
    [Abstract] [Full Text] [Related]

  • 10. Pharmacotherapy for mortality reduction in chronic obstructive pulmonary disease.
    Sin DD, Man SF.
    Proc Am Thorac Soc; 2006 Sep 01; 3(7):624-9. PubMed ID: 16963545
    [Abstract] [Full Text] [Related]

  • 11. Inhaled corticosteroids in COPD: a controversy.
    Barnes PJ.
    Respiration; 2010 Sep 01; 80(2):89-95. PubMed ID: 20501985
    [Abstract] [Full Text] [Related]

  • 12. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF.
    Ned Tijdschr Geneeskd; 2007 Oct 06; 151(40):2195-7. PubMed ID: 17969568
    [Abstract] [Full Text] [Related]

  • 13. Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization.
    Gagnon YM, Levy AR, Spencer MD, Hurley JS, Frost FJ, Mapel DW, Briggs AH.
    Respir Med; 2005 Dec 06; 99(12):1534-45. PubMed ID: 16291076
    [Abstract] [Full Text] [Related]

  • 14. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.
    Liesker JJ, Bathoorn E, Postma DS, Vonk JM, Timens W, Kerstjens HA.
    Respir Med; 2011 Dec 06; 105(12):1853-60. PubMed ID: 21802933
    [Abstract] [Full Text] [Related]

  • 15. [Pneumology. Inhaled corticosteroids in COPD: more and interesting data!].
    Rochat T.
    Rev Med Suisse; 2008 Jan 16; 4(140):155-7. PubMed ID: 18309880
    [Abstract] [Full Text] [Related]

  • 16. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS.
    Arch Intern Med; 2009 Aug 10; 169(15):1403-10. PubMed ID: 19667304
    [Abstract] [Full Text] [Related]

  • 17. [Inhaled corticosteroids for COPD].
    Dekhuijzen PN.
    Ned Tijdschr Geneeskd; 2003 Jul 19; 147(29):1398-404. PubMed ID: 12894463
    [Abstract] [Full Text] [Related]

  • 18. [Do inhaled corticosteroids reduce mortality in chronic obstructive pulmonary disease?].
    Bridevaux PO, Leuenberger P.
    Rev Med Suisse; 2005 Nov 16; 1(41):2673-4, 2677-9. PubMed ID: 16355882
    [Abstract] [Full Text] [Related]

  • 19. Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD.
    Loke YK, Kwok CS, Singh S.
    Eur Respir J; 2010 May 16; 35(5):1003-21. PubMed ID: 19926743
    [Abstract] [Full Text] [Related]

  • 20. Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients?
    Sin DD, Man SF.
    Curr Opin Pulm Med; 2007 Mar 16; 13(2):90-7. PubMed ID: 17255798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.